Drug Release Applications
-
Sustained-Release Drug Delivery Platforms for Retinal Diseases
Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...
By Glaukos Corporation based in San Clemente, CALIFORNIA (USA).
-
Highly customized aptamer discovery solutions for drug delivery sector
In many therapeutic areas, current treatments involve significant side effects. Combining drug compounds with affinity agents that target specific cell surface receptors can dramatically reduce off-target effects and improve treatment effectiveness. In several studies, aptamer-mediated drug delivery has reduced toxicity and improved drug performance. ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you